#analystconsensus — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #analystconsensus, aggregated by home.social.
-
https://www.europesays.com/news/24688/ Palantir Q1 2026 earnings: revenue surges 85%, guidance raised #AlexKarp #AnalystConsensus #Headlines #News #palantir #QuarterlyRevenue #TopStories
-
https://www.europesays.com/ch/52978/ UBS Hikes Bloom Energy’s Price Target From $170 to $251 on the 800 VDC Data Center Revolution #AnalystConsensus #BloomEnergy #DataCenter #ManavGupta #NVIDIA #PowerInfrastructure #PriceTarget #SolidOxideFuelCell #Top10AIStocks #UBS #VDCPower
-
https://www.europesays.com/ch/52911/ UBS Trims Qualcomm’s Target to $150: Why Rising Memory Prices Are Becoming a Chip Stock Headwind #AnalystConsensus #MemoryPrices #Qualcomm #Top10AIStocks #UBS
-
Novo Nordisk reported a 67% year-on-year surge in Q2 Wegovy sales, narrowly missing analyst forecasts, while overall revenue slightly beat expectations amid supply chain and competition challenges.
#YonhapInfomax #NovoNordisk #Wegovy #Q2Earnings #RevenueGrowth #AnalystConsensus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=75878 -
Novo Nordisk reported a 67% year-on-year surge in Q2 Wegovy sales, narrowly missing analyst forecasts, while overall revenue slightly beat expectations amid supply chain and competition challenges.
#YonhapInfomax #NovoNordisk #Wegovy #Q2Earnings #RevenueGrowth #AnalystConsensus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=75878 -
Novo Nordisk reported a 67% year-on-year surge in Q2 Wegovy sales, narrowly missing analyst forecasts, while overall revenue slightly beat expectations amid supply chain and competition challenges.
#YonhapInfomax #NovoNordisk #Wegovy #Q2Earnings #RevenueGrowth #AnalystConsensus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=75878 -
Novo Nordisk reported a 67% year-on-year surge in Q2 Wegovy sales, narrowly missing analyst forecasts, while overall revenue slightly beat expectations amid supply chain and competition challenges.
#YonhapInfomax #NovoNordisk #Wegovy #Q2Earnings #RevenueGrowth #AnalystConsensus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=75878